跳至主要内容
临床试验/NCT01742039
NCT01742039已完成不适用

A New Therapeutic Strategy to Reduce the Incidence of Postoperative Atrial Fibrillation

George Washington University2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2008年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
2
主要终点
occurrence of atrial fibrillation

研究概览

简要总结

The primary aim of this study is to determine the safest and most effective therapeutic strategy to decrease the incidence of postoperative atrial fibrillation following cardiac surgery in an era with shorter ICU and hospital length of stay. A secondary goal is to evaluate the length of hospital stay associated with each treatment strategy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > or = to 18 years
  • sinus rhythm
  • undergoing either coronary artery bypass graft surgery (CABG), valvular heart surgery or a combined procedure

排除标准

  • received a class-I or class-III antiarrhythmic agent in the past six months
  • had second or third degree heart block
  • had a resting heart rate of less than 50 beats per minute
  • had a systolic blood pressure less than 100 mmHg
  • had severe asthma or severe chronic obstructive pulmonary disease
  • had uncontrolled heart failure
  • had a serum aspartate aminotransferase or alanine aminotransferase concentration greater than four times the upper limit of normal

结局指标

主要结局

occurrence of atrial fibrillation

时间窗: postoperative day 0-day of discharge (an average of 5 days)

The primary endpoint of this study was the occurrence of atrial fibrillation lasting longer than five minutes

次要结局

  • length of stay(participants will be followed for the duration of hospital stay, an expected average of 5 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Prevention of Postoperative Atrial Fibrillation | 临床试验